封面
市場調查報告書
商品編碼
1692226

數位呼吸設備市場 - 全球產業規模、佔有率、趨勢、機會和預測,按產品、適應症、配銷通路、地區和競爭細分,2020-2030 年

Digital Respiratory Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Indication, By Distribution Channel, By Region and Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 184 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球數位呼吸設備市場價值為 432.1 億美元,預計到 2030 年將達到 775.4 億美元,複合年成長率為 10.21%。醫療保健產業正在經歷數位轉型,這種轉型延伸到呼吸照護領域。數位呼吸設備正在徹底改變全球呼吸疾病的管理、診斷和治療方式。這些創新設備提供即時監控、個人化治療方案和改善患者治療效果。慢性阻塞性肺病 (COPD)、氣喘和睡眠呼吸中止症等呼吸系統疾病是全球健康問題。因此,迫切需要先進的呼吸照護解決方案來幫助更有效地管理和治療這些疾病。

市場概況
預測期 2026-2030
2024 年市場規模 432.1 億美元
2030 年市場規模 775.4 億美元
2025-2030 年複合年成長率 10.21%
成長最快的領域 網路藥局
最大的市場 北美洲

數位呼吸設備已經成為醫療保健產業的重大變革。這些設備將尖端技術與呼吸護理相結合,提供了許多益處。數位呼吸設備提供有關患者肺功能和呼吸模式的即時資料。這種持續的監測使醫療保健提供者能夠做出明智的決定並根據需要調整治療計劃。借助資料分析和機器學習演算法,這些設備可以根據每位患者的獨特需求量身定做治療方案。這種個人化的方法提高了治療效果和患者滿意度。患者可以在家中使用數位呼吸設備,減少頻繁就診的需要。醫療專業人員可以遠端監控患者病情進展,確保在病情惡化時儘早介入。許多數位呼吸設備都具有鼓勵患者遵守治療計劃的功能。這些可能包括提醒、遊戲化元素和教育資源。

主要市場促進因素

呼吸系統疾病的增加推動了全球數位呼吸設備市場的發展

主要市場挑戰

資料安全和隱私問題

主要市場趨勢

技術進步

目錄

第 1 章:產品概述

第 2 章:研究方法

第 3 章:執行摘要

第 4 章:顧客之聲

第5章:全球數位呼吸設備市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按產品(智慧型吸入器和霧化器、感測器和應用程式、其他)
    • 依適應症分類(氣喘、慢性阻塞性肺病、其他)
    • 按配銷通路(醫院藥房、零售藥房、網路藥房)
    • 按地區
    • 按公司分類(2024)
  • 市場地圖

第 6 章:北美數位呼吸設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美:國家分析
    • 加拿大
    • 墨西哥

第 7 章:歐洲數位呼吸設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲:國家分析
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章:亞太地區數位呼吸設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區:國家分析
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章:南美洲數位呼吸設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲:國家分析
    • 阿根廷
    • 哥倫比亞

第 10 章:中東和非洲數位呼吸設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA:國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章:市場動態

  • 驅動程式
  • 挑戰

第 12 章:市場趨勢與發展

  • 近期發展
  • 合併與收購
  • 產品發布

第 13 章:全球數位呼吸設備市場:SWOT 分析

第 14 章:波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章:競爭格局

  • COHERO Health Inc.
  • Cognita Labs llc
  • Adherium Limited
  • Amiko Digital Health Limited
  • Teva Pharmaceuticals Industries Ltd.
  • Propeller Health
  • Novartis AG
  • Pneuma Respiratory Inc.
  • 3M Health Care Limited
  • AireHealth, Inc.

第 16 章:策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 17473

Global Digital Respiratory Devices Market was valued at USD 43.21 Billion in 2024 and is expected to reach USD 77.54 Billion in the forecast period with a CAGR of 10.21% through 2030. The healthcare industry is undergoing a digital transformation, and this transformation extends to the field of respiratory care. Digital respiratory devices are revolutionizing the way respiratory conditions are managed, diagnosed, and treated worldwide. These innovative devices offer real-time monitoring, personalized treatment plans, and improved patient outcomes. Respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea, are a global health concern. As a result, there is an urgent need for advanced respiratory care solutions that can help manage and treat these conditions more effectively.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 43.21 Billion
Market Size 2030USD 77.54 Billion
CAGR 2025-203010.21%
Fastest Growing SegmentOnline Pharmacies
Largest MarketNorth America

Digital respiratory devices have emerged as a game changer in the healthcare industry. These devices combine cutting-edge technology with respiratory care, offering numerous benefits. Digital respiratory devices provide real-time data on a patient's lung function and breathing patterns. This continuous monitoring allows healthcare providers to make informed decisions and adjust treatment plans as needed. With the help of data analytics and machine learning algorithms, these devices can tailor treatment plans to each patient's unique needs. This personalized approach enhances treatment effectiveness and patient satisfaction. Patients can use digital respiratory devices at home, reducing the need for frequent clinic visits. Healthcare professionals can remotely monitor patients' progress, ensuring early intervention in case of deterioration. Many digital respiratory devices come with features that encourage patient adherence to treatment plans. These may include reminders, gamification elements, and educational resources.

Key Market Drivers

Rising Respiratory Disorders is Driving the Global Digital Respiratory Devices Market

Respiratory disorders have been on the rise worldwide, affecting millions of people and posing a significant healthcare challenge. Conditions such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea have become increasingly prevalent due to factors like air pollution, smoking, and lifestyle changes. In response to this growing health concern, the global digital respiratory devices market has emerged as a crucial player in managing and monitoring these conditions effectively.

Respiratory disorders encompass a wide range of conditions that affect the lungs and airways, making it difficult for individuals to breathe properly. These disorders include asthma, COPD, pneumonia, bronchitis, and sleep apnea, among others. According to the World Health Organization (WHO), respiratory diseases are the leading cause of death worldwide, accounting for 10% of all deaths. This alarming statistic highlights the urgent need for better management and monitoring of respiratory health.

Several factors contribute to the rising prevalence of respiratory disorders. Poor air quality caused by industrial emissions, vehicular pollution, and other environmental factors can trigger and exacerbate respiratory conditions. Tobacco use remains a significant risk factor for respiratory disorders, including lung cancer, COPD, and emphysema. As more people move to cities, exposure to indoor and outdoor air pollutants increases, potentially leading to respiratory health problems. Sedentary lifestyles and unhealthy dietary habits have contributed to the rise of obesity, which is linked to respiratory conditions such as sleep apnea.

Digital respiratory devices have emerged as a crucial tool in the management and monitoring of respiratory conditions. These devices leverage cutting-edge technology to provide patients and healthcare professionals with real-time data and insights, enabling better disease management and improved quality of life. Digital respiratory devices, such as smart inhalers and continuous positive airway pressure (CPAP) machines for sleep apnea, collect and transmit data to healthcare providers. This data helps healthcare professionals monitor patients' progress and make necessary adjustments to their treatment plans. Smart inhalers are equipped with sensors that track inhaler usage. They remind patients to take their medication and provide feedback on technique, improving adherence to treatment regimens. Patients can now be monitored remotely, reducing the need for frequent clinic visits. This is especially beneficial during pandemics and for patients in remote areas. Digital respiratory devices allow for more personalized treatment plans. Healthcare providers can tailor interventions based on an individual's specific needs and responses to therapy.

Recent data from the World Health Organization (WHO) underscores the severity of respiratory diseases globally. In 2021, chronic obstructive pulmonary disease (COPD) was the fourth leading cause of death worldwide, resulting in approximately 3.5 million deaths, which accounts for about 5% of all global deaths. Additionally, air pollution remains a critical factor, with WHO reporting that almost the entire global population (99%) breathes air that exceeds WHO air quality limits, leading to significant health risks. These statistics highlight the pressing need for effective management and monitoring solutions, such as digital respiratory devices, to combat the escalating burden of respiratory disorders.

Key Market Challenges

Data Security and Privacy Concerns

Data security and privacy concerns present a significant challenge for the global digital respiratory devices market as these devices collect, store, and transmit sensitive patient health information. The integration of digital technologies, such as smart inhalers, connected nebulizers, and remote monitoring systems, relies on cloud-based platforms and mobile applications to facilitate real-time tracking and personalized treatment plans. Patients' medical histories, treatment adherence patterns, and respiratory health data are transmitted to healthcare providers, increasing the risk of cyber threats and data breaches. Unauthorized access to such data can compromise patient confidentiality, leading to potential misuse of personal health information by cybercriminals, insurance companies, or unauthorized third parties.

Regulatory frameworks, including the Health Insurance Portability and Accountability Act (HIPAA) in the United States and the General Data Protection Regulation (GDPR) in Europe, impose strict guidelines on healthcare data security. Compliance with these regulations requires significant investments in encryption technologies, secure cloud storage solutions, and cybersecurity protocols. Many digital respiratory device manufacturers and healthcare providers face challenges in meeting these stringent standards while ensuring seamless data access for patients and clinicians. Any failure to comply with these regulations can result in legal penalties, reputational damage, and loss of consumer trust.

Key Market Trends

Technological Advancements

The healthcare industry has witnessed a remarkable transformation in recent years, primarily due to advancements in technology. One such area where technology has made substantial strides is in respiratory care. Digital respiratory devices have emerged as game-changers in the field, significantly improving the management of respiratory conditions. As a result, the global digital respiratory devices market is experiencing rapid growth, driven by innovative technologies that enhance patient care and revolutionize the way respiratory diseases are managed.

Smart inhalers have gained prominence as a breakthrough technology for managing conditions like asthma and COPD. These inhalers are equipped with sensors that monitor medication usage and inhalation technique. Patients can receive real-time feedback and reminders through smartphone apps, ensuring they adhere to their treatment plans. Internet of Things (IoT) technology has enabled the development of remote monitoring devices. These devices can track a patient's vital signs, oxygen levels, and lung function from the comfort of their homes. Healthcare providers can remotely assess data, make necessary adjustments to treatment plans, and intervene promptly when needed, reducing hospital admissions and emergency room visits. The integration of telemedicine and telehealth platforms with digital respiratory devices has enabled virtual consultations and remote disease management. Patients can consult with healthcare professionals, receive prescriptions, and access educational resources without leaving their homes. AI-powered algorithms are being utilized to analyze vast datasets generated by digital respiratory devices. This technology can predict disease exacerbations, identify trends, and provide personalized treatment recommendations based on individual patient data. Interoperability between different digital respiratory devices and electronic health records (EHRs) streamlines the sharing of patient information among healthcare providers. This connectivity enhances care coordination and ensures a holistic approach to managing respiratory conditions.

Key Market Players

  • COHERO Health Inc.
  • Cognita Labs llc
  • Adherium Limited
  • Amiko Digital Health Limited
  • Teva Pharmaceuticals Industries Ltd.
  • Propeller Health
  • Novartis AG
  • Pneuma Respiratory Inc.
  • 3M Health Care Limited
  • AireHealth, Inc.

Report Scope:

In this report, the Global Digital Respiratory Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital Respiratory Devices Market, By Product:

  • Smart Inhalers & Nebulizers
  • Sensors & Apps
  • Others

Digital Respiratory Devices Market, By Indication:

  • Asthma
  • COPD
  • Others

Digital Respiratory Devices Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Digital Respiratory Devices Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Respiratory Devices Market.

Available Customizations:

Global Digital Respiratory Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Digital Respiratory Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Smart Inhalers & Nebulizers, Sensors & Apps, Others)
    • 5.2.2. By Indication (Asthma, COPD, Others)
    • 5.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Digital Respiratory Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Indication
    • 6.2.3. By Distribution Channel
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Digital Respiratory Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Indication
        • 6.3.1.2.3. By Distribution Channel
    • 6.3.2. Canada Digital Respiratory Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Indication
        • 6.3.2.2.3. By Distribution Channel
    • 6.3.3. Mexico Digital Respiratory Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Indication
        • 6.3.3.2.3. By Distribution Channel

7. Europe Digital Respiratory Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Indication
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Digital Respiratory Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Indication
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. United Kingdom Digital Respiratory Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Indication
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. Italy Digital Respiratory Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Indication
        • 7.3.3.2.3. By Distribution Channel
    • 7.3.4. France Digital Respiratory Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Indication
        • 7.3.4.2.3. By Distribution Channel
    • 7.3.5. Spain Digital Respiratory Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Indication
        • 7.3.5.2.3. By Distribution Channel

8. Asia-Pacific Digital Respiratory Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Indication
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Digital Respiratory Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Indication
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. India Digital Respiratory Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Indication
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. Japan Digital Respiratory Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Indication
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. South Korea Digital Respiratory Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Indication
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Australia Digital Respiratory Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Indication
        • 8.3.5.2.3. By Distribution Channel

9. South America Digital Respiratory Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Indication
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Digital Respiratory Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Indication
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. Argentina Digital Respiratory Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Indication
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. Colombia Digital Respiratory Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Indication
        • 9.3.3.2.3. By Distribution Channel

10. Middle East and Africa Digital Respiratory Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Indication
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Digital Respiratory Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Indication
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Saudi Arabia Digital Respiratory Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Indication
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. UAE Digital Respiratory Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Indication
        • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Digital Respiratory Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. COHERO Health Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Service Offerings
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Cognita Labs llc
  • 15.3. Adherium Limited
  • 15.4. Amiko Digital Health Limited
  • 15.5. Teva Pharmaceuticals Industries Ltd.
  • 15.6. Propeller Health
  • 15.7. Novartis AG
  • 15.8. Pneuma Respiratory Inc.
  • 15.9. 3M Health Care Limited
  • 15.10. AireHealth, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer